RE: Galleri blood test on BBC news and in Daily mail today. Angle5 Jun 2023 09:12
Emerald. The capture rate for intact cancer cells in early malignancy is likely to be exceedingly small, and as a screening test Parsortix is, sadly, of no value. The Grail process, using fragments, seems to be improving in the early detection of suspected, or even unsuspected malignancy. I wonder whether AI might make this process even more accurate. But it will never supplant Parsortix as a means of careful analysis of all aspects of the cancer cell which is going to be of value in determining the correct therapeutic approach.
PS analysis? (analisis might mean something else......)